Zacks Investment Management Moderna, Inc. Transaction History

Zacks Investment Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $155,788 - $276,412	1,316 New	1,316 $236,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $129,662 - $195,485	-1,107 Reduced 6.16%	16,854 $2.41 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $167,053 - $310,501	1,321 Added 7.94%	17,961 $3.09 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $335,342 - $547,237	1,485 Added 9.8%	16,640 $4.23 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $1.47 Million - $3.2 Million	-6,605 Reduced 30.35%	15,155 $5.83 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $187,330 - $338,841	1,442 Added 7.1%	21,760 $5.11 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $2.22 Million - $3.78 Million	20,318 New	20,318 $2.66 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.